We therefore extracted the first available stored serum sample for 501 patients with SLE, tested these samples for IgG aCL, IgG anti-β2GPI and IgG anti-DI, and compared these serological profiles to clinical outcomes of death or VE during the subsequent follow-up period. This evidence concerns the gene ACLY and systemic lupus erythematosus.